BioCity creates, develops and provides investment, facilities and support to early stage life science companies. Glenn has a first degree in Genetics from Nottingham University and a D Phil in Immunology from Oxford University. After a few years in post doctoral research, he joined Ernst & Young where he qualified as a chartered accountant. His work with E&Y focused on advising the biotechnology industry, spending several years in Palo Alto, California, and returning to Cambridge to head the UK biotechnology practice for the firm. He is founder of R5 Pharmaceuticals Ltd and Mobius Life Sciences Fund and is a board member of CompanDx, XenoGesis and several other businesses. Glenn also acts as an adviser to developers and operators of bioincubators and science parks and is a founder member and Chairman of the UK Bioincubator forum.